Looking Beyond the Diagnosis
Cancer is more than a name or a stage. Understanding the molecular profile of a tumour helps your oncology team make more informed treatment decisions.
Cancer Treatments
Understanding Targeted Therapy
Not every cancer behaves in the same way, which means not every treatment should either. Advances in cancer care have made it possible to identify specific changes within certain cancer cells, allowing treatment to be chosen with greater precision.
Targeted therapy for cancer uses medicines that focus on particular genes, proteins, or molecular changes that help cancer grow and spread. Unlike treatments that affect rapidly dividing cells throughout the body, targeted drug therapy for cancer is designed to act on specific cancer-related pathways, making it an important treatment option for selected patients.
Because targeted therapy is only effective for cancers with certain molecular characteristics, specialised testing is often carried out before treatment begins. At IOHC, every recommendation is based on a careful evaluation of your diagnosis, biomarker results, and overall health to ensure the treatment is appropriate for your individual condition.
When Might Targeted Therapy Be Recommended?
Targeted therapy is recommended only when specific genetic or molecular changes are identified within a tumour. These changes are usually detected through specialised laboratory or genomic testing, helping your oncology team determine whether targeted therapy for cancer treatment may be beneficial.
Your oncologist may recommend targeted therapy if:
- Your tumour shows specific genetic or molecular markers.
- Testing confirms that targeted medicines may be effective.
- Your treatment plan includes targeted therapy alone or alongside other treatments.
- You have cancers such as lung cancer or other cancers where targeted therapy is well established.
- A personalised treatment approach is considered the most appropriate option.
Finding the Right Treatment Approach
The success of targeted therapy begins with understanding the biology of your cancer. Rather than taking a one-size-fits-all approach, every treatment decision is guided by detailed diagnostic information that helps identify the therapies most likely to benefit you.
Guided by Biomarker Testing
Specialised laboratory and genomic testing help determine whether targeted therapy for cancer is likely to be effective, ensuring treatment is recommended only when it is clinically appropriate.
Selecting the Right Treatment
Every recommendation considers your diagnosis, genetic findings, overall health, and treatment goals, creating a plan that reflects your individual needs.
Reviewing Your Progress
Throughout treatment, your response is carefully monitored through regular consultations, investigations, and clinical assessments, allowing your care team to adapt your plan whenever required.
Continuing Care Beyond Treatment
Cancer care continues long after treatment begins. Regular follow-ups, supportive care, and ongoing guidance help ensure your wellbeing remains at the centre of every decision.
Preparing for Targeted Therapy
Targeted therapy begins long before your first dose. Understanding your diagnosis, completing the recommended tests, and staying connected with your oncology team help ensure the treatment is appropriate for your condition and continues to work as planned.
Do's
- Keep all your diagnostic reports and biomarker test results organised.
- Take your medications exactly as prescribed by your oncologist.
- Inform your care team about any new symptoms or side effects.
- Attend scheduled follow-up visits and recommended investigations.
- Maintain a healthy lifestyle to support your overall wellbeing during treatment.
Don'ts
- Do not stop treatment without consulting your oncologist.
- Avoid starting new medicines or supplements without medical advice.
- Do not miss follow-up appointments or monitoring tests.
- Avoid ignoring even mild side effects or changes in your health.
- Do not rely on online information to make treatment decisions.
Care That Adapts with You
Targeted therapy is not a one-time decision. As treatment progresses, your response is regularly assessed to ensure the therapy continues to meet your needs.
At IOHC, every targeted therapy for cancer plan is supported by ongoing clinical reviews, regular investigations, and coordinated follow-up care. By closely monitoring your progress, our team can make informed decisions, manage side effects, and adapt your treatment whenever required, helping you receive care that remains aligned with your diagnosis and overall wellbeing.
Request AppointmentFrequently Asked Questions
Questions About Targeted Therapy
Targeted therapy for cancer is a treatment that uses medicines to act on specific genes, proteins, or molecular changes that help cancer grow. Unlike traditional treatments, targeted drug therapy for cancer focuses on cancer-specific pathways, making it suitable only for patients whose tumours have certain genetic or molecular characteristics.
Targeted therapy may help to:
- Slow or stop the growth of cancer cells.
- Target specific molecular changes within the tumour.
- Support a more personalised treatment approach.
Not every patient is suitable for targeted therapy for cancer treatment. Eligibility depends on the type of cancer, biomarker or genetic test results, and your overall health. Your oncologist will recommend cancer treatment targeted therapy only if specialised testing shows that it is likely to benefit your condition.
Eligibility is based on:
- Your cancer type and stage.
- Biomarker or genetic test results.
- Your individual treatment plan.
While chemotherapy affects rapidly dividing cells throughout the body, targeted therapy for cancer focuses on specific molecular changes within cancer cells. This allows targeted oncology treatments to work in a more selective way for patients whose cancers have identifiable treatment targets.
The main differences include:
- Treatment is guided by biomarker testing.
- Medicines act on specific cancer pathways.
- Not every cancer is suitable for targeted therapy.
Yes. Depending on your diagnosis, targeted therapy for cancer treatment may be combined with chemotherapy, immunotherapy, surgery, or radiation therapy to achieve the most appropriate outcome. Your oncologist will recommend the combination best suited to your individual needs.
Treatment may be combined with:
- Chemotherapy.
- Immunotherapy.
- Surgery or radiation therapy.
Yes. Lung cancer treatment targeted therapy is commonly recommended when specialised testing identifies specific genetic changes within the tumour. These results help determine whether targeted therapy for cancer is likely to be an effective treatment option.
Treatment decisions are based on:
- Molecular or genetic testing.
- The type of lung cancer.
- Your overall treatment goals.
Like all cancer treatments, targeted drug therapy for cancer can cause side effects, although these vary depending on the medicines prescribed and the individual's response. Most side effects can be monitored and managed through regular follow-up during targeted therapy for cancer.
Some patients may experience:
- Skin changes or rashes.
- Fatigue.
- Digestive or appetite-related changes.
The decision to recommend targeted therapy for cancer treatment is based on a detailed evaluation of your diagnosis, biomarker testing, and overall health. At IOHC, every patient undergoes a comprehensive assessment to determine whether targeted oncology approaches are appropriate and likely to provide clinical benefit.
Your assessment may include:
- Review of biopsy and pathology reports.
- Biomarker or genomic testing.
- Personalised treatment planning with your oncology team.
Related Cancer Treatments
Visit IOHC — Mumbai
1101, 11th Floor, Shrikant Chamber-2 Next to R.K Studio, Union Park, Chembur Mumbai, Maharashtra 400071
Get Directions